Skip to main content

Why The Next Biotech Boom Could be Sparked by New Therapies for Neurological Disorders · BioBuzz

By December 9, 2019News
Artificial Intelligence Brain Free image on Pixabay

Artificial Intelligence Brain Free image on Pixabay

A Maryland-based biotechnology firm seems to have solved a puzzling issue for drug targeting and delivery that may usher in an era of gene therapies for neurological disorders. Rockville, Maryland’s REGENXBIO’s NAV Technology Platform provides the ability to treat neurological disorders by targeting specific disease-related genes or gene products. Their patented technology glides across the blood-brain barrier (BBB) without triggering the patient’s immune system as with unengineered adeno-associated virus (AAV)-derived vectors, providing localized gene delivery with few side effects.

Image: https://biobuzz.io

{iframe}https://biobuzz.io/why-new-therapies-for-neurological-disorders-could-spark-the-next-biotech-boom/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.